Technology Times Somalia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times Somalia.

Press releases published on June 3, 2026

Jun. 3, 2026

Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

Jun. 3, 2026

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF

Indeterminate GlobeNewswire

Jun. 3, 2026

OwlTing Group (NASDAQ: OWLS) Secures Ohio Money Transmitter License, Extending U.S. Coverage to 42 States

Indeterminate GlobeNewswire

Jun. 3, 2026

Token Security Launches Enzo, the AI-Native Application Builder That Operationalizes Identity Security

Indeterminate GlobeNewswire

Jun. 3, 2026

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

Indeterminate GlobeNewswire

Jun. 3, 2026

Hopstem hNPC01 Cell Injection Earns FDA RMAT Designation for Chronic Stroke Therapy

Indeterminate GlobeNewswire

Jun. 3, 2026

IP Strategy Publishes Monthly Validator Update

Indeterminate GlobeNewswire

Jun. 3, 2026

Pure DC Demonstrates Gas Connected Data Centres can be Decarbonised at Operational Scale with Europe’s First Large-Scale Cross-Border Biomethane Deal

Indeterminate GlobeNewswire

Jun. 3, 2026

Francisco Ranzi Müller Leads the MicAi-X Technology Upgrade, Bringing Automated Trading Capabilities Into a New Cycle

Indeterminate GlobeNewswire

Jun. 3, 2026

Francisco Ranzi Müller lidera a atualização tecnológica do MicAi-X, iniciando um novo ciclo para as capacidades de negociação automática

Indeterminate GlobeNewswire

Jun. 3, 2026

Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Indeterminate GlobeNewswire

Jun. 3, 2026

Dentsu extends Magnite partnership to streamline CTV activation across Sweden

Indeterminate GlobeNewswire

Jun. 3, 2026

Enginuity Skills Awards 2026 – The ‘Oscars of Skills’

Indeterminate GlobeNewswire

Jun. 3, 2026

Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders

Indeterminate GlobeNewswire

Jun. 3, 2026

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative

Indeterminate GlobeNewswire

Jun. 3, 2026

Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc

Indeterminate GlobeNewswire

Jun. 3, 2026

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Indeterminate GlobeNewswire

Jun. 3, 2026

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

SEALSQ Participates as a Lead Investor in Quobly’s €130 Million Series A Financing Via SEALQuantum.com Fund to Advance the European Sovereign Quantum Infrastructure

Indeterminate GlobeNewswire